Scientific Sessions
Dated 23.10.2020*
12:30-12:35
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
12:35-12:40
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel
12:40-12:45
Mr. Yuli (Yoel) Edelstein
Minister of Health, Israel
12:45-13:15
IF WE CANNOT CHANGE THE FUTURE AT LEAST WE CAN CHANGE OUR ATTITUDE
Prof. Dedi Meiri
Assistant Professor, Heads the ``Laboratory of Cancer Biology and Cannabinoid Research``, Technion, Israel Institute of Technology, Israel
13:15-13:30
Live Discussion/Q&A
14:00-14:30
MEDICAL GRADE CANNABIS: DEFINITIONS AND CONCEPTS
Dr. Raquel Peyraube
Executive Committee, the International Association for Cannabinoid Medicines, Uruguay
14:30-14:45
Live Discussion/Q&A
PARALLEL SESSIONS
.
Innovations in Science and Medicine
14:45-16:00
GRAND ROUNDS: REAL-LIFE STORIES FROM THE CLINICAL PRACTICE
14:45-15:05
Dr. Orit Stolar
Pediatric Neurologist, Assaf Harofeh Medical Center, Israel
15:25-15:45
Dr. Addie Ron
Medical Director, NiaMedic, Israel
15:20-15:40
Dr. Bareket Schiff Keren
Pain Specialist, Tel Aviv Medical Center, Israel
15:45-16:00
Live Discussion/Q&A
14:45-15:45
LIVE SESSION – CULTIVATING SCIENCE IN THE MEDICAL CANNABIS BUSINESS
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
16:30-17:30
COVID-19, CBD AND CANNABIS
16:30-16:50
THE YIN AND YANG OF THE ENDOCANNABINOID SYSTEM IN IMMUNOCOMPETENCE: IMPLICATIONS FOR COVID-19
Dr. Michelle Sexton
Assistant Adjunct Professor, Department of Anesthesiology, Voluntary Clinical Instructor, Department of Family Medicine and Public Health, University of San Diego California, USA
16:50-17:10
CANNABINOIDS AS ADJUNCT ANTI-VIRAL THERAPY FOR INFLAMMATION ASSOCIATED WITH SARS-COV2
Prof. Siddappa N. Byrareddy
Associate Professor, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, USA
17:10-17:30
Live Discussion/Q&A
16:30-17:30
LIVE SESSION – PANEL DISCUSSION: WOMEN IN THE FOREFRONT OF CANNABIS INNOVATION
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
Industry session not included in the main event CME/CPD credit
13:45-14:10
CANNABIS PLANT SCIENCE: INTERPLAY BETWEEN CANNABINOIDS AND ENVIRONMENTAL CONDITIONS
Dr. Nirit Bernstein
Senior Research Scientist, ARO, Volcani Institute, Israel
14:10-14:20
Live Discussion/Q&A
Industry session not included in the main event CME/CPD credit
Industry session not included in the main event CME/CPD credit
PARALLEL SESSIONS
.
Innovations in Science and Medicine
15:30-16:30
LIVE SESSION – ROUND TABLE DISCUSSION: PUBLIC HEALTH IMPLICATIONS
15:30-15:50
SELF-MEDICATION WITH CANNABIS: THE ASSOCIATION BETWEEN PHYSICAL PAIN, SLEEP AND CANNABIS USE IN DAILY LIFE OF RECREATIONAL CANNABIS USERS
Dr. Sharon Sznitman
Lecturer, School of Public Health, University of Haifa, Israel
15:50-16:10
HOW TO IMPROVE RATIONALITY IN NATIONAL AND INTERNATIONAL POLICIES ON MEDICAL CANNABIS
Prof. David Nutt
Professor, Imperial College London, UK
16:10-16:30
Live Q&A
15:30-16:30
LIVE SESSION – THE INTERPLAY OF SCIENCE, BUSINESS AND LAW
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
17:00-17:45
LIVE SESSION – ROUND TABLE DISCUSSION: CANNABINOIDS AND THE ELDERLY
Dr. Dustin Sulak
M.D., Founder and Medical Director, Healer.com, USA
Dr. Jeffrey Hergenrather
Founding member, Society of Cannabis Clinicians, USA
17:35-17:45
Live Q&A
17:00-17:45
WORKSHOP: CANNABIS EXTRACTION AND PURIFICATION METHODS: YOU NEED TO FOCUS IN COMPLIANCE AND THE FINAL PRODUCT REQUIRED
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
17:45-19:00
MEDICAL CANNABIS AND CANCER CARE
17:45-18:05
THE ANTI-CANCER POTENTIAL OF CANNABINOIDS
Prof. Manuel Guzman
Professor of Biochemistry and Molecular Biology at Madrid Complutense University, Spain
18:05-18:25
CBD FOR TREATMENT OF GRAPH-VERSUS-HOST DISEASE
Dr. Moshe Yeshurun
Head of Bone Marrow Transplantation Unit, Rabin Medical Center, Israel
18:25-18:45
INTEGRATING CANNABIS INTO CANCER CARE
Prof. Donald Abrams
Chief of the Hematology-Oncology Division, San Francisco General Hospital and a Professor of Clinical Medicine, the University of California San Francisco, USA
18:45-19:00
Live Discussion/Q&A
17:45-18:45
INTEGRATING SCIENCE AND BUSINESS: A BRAZILIAN PERSPECTIVE
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
15:30-16:15
MEDICAL CANNABIS TREATMENTS: CLINICAL CONSIDERATIONS: PART A
15:30-15:45
THE WORLD OF CANNABIS
Dr. Uma Dhanabalan
Founder/CEO Global Health & Hygiene Solutions, LLC / Uplifting Health & Wellness, USA
15:45-16:00
TREATING CHILDREN WITH MEDICAL CANNABIS
Dr. Bonni Goldstein
Medical Director and Owner, Canna-Centers Wellness & Education, USA
16:00-16:15
Live Discussion/Q&A
15:30-16:30
LIVE SESSION – ROUND TABLE DISCUSSION: MEDICAL CANNABIS AND THE ROLE OF PHARMACISTS: THE ISRAELI EXPERIENCE
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
PARALLEL SESSIONS
.
Innovations in Science and Medicine
16:15-17:00
MEDICAL CANNABIS TREATMENTS: CLINICAL CONSIDERATIONS: PART B
16:15-16:30
SIDE-EFFECTS AND ADVERSE EFFECTS OF CANNABINOID MEDICINES
Dr. Franjo Grotenhermen
Executive Director, International Association for Cannabinoid Medicines IACM, Germany
16:30-16:45
INTERACTIONS OF CANNABINOIDS WITH OTHER TREATMENTS
Prof. Marta Vázquez
Professor, Pharmaceutical Sciences Department, Faculty of Chemistry, Universidad de la República, Montevideo, Uruguay
16:45-17:00
Live Discussion/Q&A
16:45-17:30
MEET THE EXPERTS: CLINICAL STUDIES AND MEDICAL CANNABIS
Industry session not included in the main event CME/CPD credit
Click HERE for the session content
17:30-17:50
TUNING THE ENDOCANNABINOID SYSTEM: WHEN TREATMENT MATCHES THE PATIENT
Dr. Fabricio Pamplona
Head of Science – CSO, Proprium Health Technology and Science, Brazil
17:50-18:10
SELECTION AND DOMESTICATION OF CANNABIS STRAINS AS A BASIS FOR MEDICINE DEVELOPMENTS
Prof. Hinanit Koltai
Senior Research Scientist, Agricultural Research Organization, Volcani Center, Israel
18:10-18:30
TOPICAL CANNABIS-BASED MEDICINES (TCBM): A NOVEL PARADIGM FOR INTEGUMENTARY & WOUND MANAGEMENT
Dr. Vincent Maida
Associate Professor, University of Toronto, Canada
18:30-18:45
Live Discussion/ Q&A
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel